Comparative responsiveness and pharmacokinetics of doxorubicin in human tumor xenografts
✍ Scribed by Karsten Wassermann; Søren N. Rasmussen
- Book ID
- 118013519
- Publisher
- Elsevier Science
- Year
- 1987
- Weight
- 761 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In an attempt to understand the underlying cellular/ biochemical factors of sensitivityhesistance in human smallcell lung cancer (SCLC), 2 SCLC tumor lines were compared with respect to tumor responsiveness to drug treatment, cell sensitivity, cellular doxorubicin accumulation, and DNA topoisomerase
The pharmacokinetics of doxorubicin (DOX), iodo-doxorubicin (I-DOX) and their metabolites in plasma has been examined in five patients each receiving 50 mg/m2 of both anthracyclines as a bolus injection. Terminal half-life, mean residence time (MRT), peak plasma concentration Cmax, and area under th